However, in another prospective randomized controlled study involving 120 cases (28), the clinical and radiographic efficacy of using recombinant human bone morphogenetic protein-7 (rhBMP-7) combined with PRP for treating long bone fracture nonunions was found to be inferior to that of the rhBMP-7 group. Here, BMP7 is linked to Recurrent long bone fractures.